THYROID CARCINOMA-ASSOCIATED GENETIC MUTATIONS ALSO OCCUR IN THYROID LYMPHOMAS

Molecular testing for mutations activating the mitogen-associated protein kinase signaling pathway is being used to help diagnose thyroid carcinomas. However, the prevalence of these mutations in thyroid lymphomas has not been reported. Therefore, we studied the prevalence of BRAF, NRAS, HRAS, and K...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Aggarwal, Nidhi, Swerdlow, Steven H., Kelly, Lindsey M., Ogilvie, Jennifer B., Nikiforova, Mariana N., Sathanoori, Malini, Nikiforov, Yuri E.
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434253/
https://ncbi.nlm.nih.gov/pubmed/22575864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/modpathol.2012.73
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires